Restrictive Insurance Coverage Linked to Increased MS Relapse Rates
Study reveals limited insurance coverage for multiple sclerosis drugs increases relapse risk, highlighting Medicare plan disparities and formulary restrictions.
Medicare Expansion for GLP-1 Agonists Balances Clinical Gains and Cost Risks
New analysis projects increased Medicare spending with expanded GLP-1 receptor agonist coverage for obesity, highlighting clinical benefits and financial challenges.